Company / Capital Expenditures
KESTRA MEDICAL TECHNOLOGIES, LTD. Capital Expenditures History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$22.9M
FY2024
5-year range
$12.2M / $22.9M
FY2023-FY2024
Trend
+87.6%
vs FY2023
Sector context
#102 of 151
Health Care
What the data says
At $23M, KESTRA MEDICAL TECHNOLOGIES, LTD.'s capital expenditures ranks #102 of 151 in the Health Care sector.
Based on SEC 10-K filings.
$23M in FY2024.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#102 of 151 in Health CareTop 68% of 151This company $22.9M Sector average $271.7M
▼
-91.6% below sector average
Key checks
Key Insights
- In FY2024, capital expenditures increased 87.6% year-over-year.
- Ranks #102 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $22.9M | +87.6% |
| FY2023 | $12.2M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026